AstraZeneca is now bigger than Pfizer, but what's the secret of CEO Soriot's success?Proactive Investors • 04/24/23
AstraZeneca results arrive with focus on drug trials, while GSK still faces Zantac overhangProactive Investors • 04/21/23
Astrazeneca (AZN) is a Top Dividend Stock Right Now: Should You Buy?Zacks Investment Research • 04/17/23
New analysis of Phase II data at AACR assesses ImaginAb's investigational CD8 ImmunoPET technology's ability to predict response in immunotherapyPRNewsWire • 04/14/23
AstraZeneca reinforces commitment to advancing science for patients with chronic kidney disease and hyperkalemia at NKF Spring Clinical Meeting 2023Business Wire • 04/11/23
Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian CancerInvestors Business Daily • 04/05/23